EVR Research’s Aspen Aerogels ASPN Stock Holding History

EVR Research’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-275,000	Closed	-$3.24M	–	37
2022 Q4	$3.24M	Buy	+275,000	New	+$3.14M	0.98%	26

Other funds holding ASPN

KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $2.81B AUM 198.36% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

EVR Research's ASPN Position: Q1 2023 in Review

EVR Research sold out of Aspen Aerogels (ASPN) in Q1 2023, closing a stake of 275,000 shares — an estimated $3.24M sold.

EVR Research first reported a position in ASPN in Q4 2022 and held it in 1 quarter. The position peaked at $3.24M in Q4 2022. 156 funds tracked by Wall St. Rank hold ASPN as of Q1 2023.

EVR Research reported no remaining Aspen Aerogels position as of Q1 2023 after selling out during the quarter.
EVR Research sold 275,000 Aspen Aerogels shares in Q1 2023, an estimated $3.24M.
EVR Research first reported a position in Aspen Aerogels in Q4 2022 and held it in 1 quarter.
EVR Research's Aspen Aerogels position peaked at $3.24M in Q4 2022.
156 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2023.

Based on EVR Research's 13F filing for Q1 2023, filed 15 May 2023.